Breath analysis of hydrogen peroxide as a diagnostic tool

Clinica Chimica Acta

Volumn 411, Issue 23-24, 2010, Pages 1849-1861

  Stolarek, Robert ^a   Bialasiewicz, Piotr ^a   Krol, Maciej ^a   Nowak, Dariusz ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Exhaled breath condensate; Hydrogen peroxide; Lung

Indexed keywords

ACETYLCYSTEINE; ANTIBIOTIC AGENT; BECLOMETASONE; DEXAMETHASONE; FLUTICASONE; HYDROGEN PEROXIDE; IPRATROPIUM BROMIDE; ISONIAZID; LYPRINOL; MONTELUKAST; PLACEBO; PREDNISOLONE; PROSTAGLANDIN E1; PYRAZINAMIDE; RIFAMPICIN; SALBUTAMOL; STREPTOMYCIN;

ADULT RESPIRATORY DISTRESS SYNDROME; ANTIINFLAMMATORY ACTIVITY; ASTHMA; BREATH ANALYSIS; CHRONIC KIDNEY FAILURE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; COMMUNITY ACQUIRED PNEUMONIA; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; DISEASE COURSE; DISEASE EXACERBATION; DOSE RESPONSE; DRUG DOSE REDUCTION; EXHALATION; HEMODIAFILTRATION; HEMODIALYSIS; HUMAN; INTERSTITIAL LUNG DISEASE; LOWER RESPIRATORY TRACT INFECTION; LUNG INFECTION; LUNG TUBERCULOSIS; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; REVIEW; UREMIA;

ANIMALS; BIOLOGICAL MARKERS; BREATH TESTS; CLINICAL CHEMISTRY TESTS; DIAGNOSIS; EXHALATION; HUMANS; HYDROGEN PEROXIDE;

EID: 77957750867     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2010.08.031     Document Type: Review

References (104)

1. McFadden E.R. Respiratory heat and water exchange: physiological and clinical implications. J Appl Physiol 1983, 54:331-336.
2. Papineni R.S., Rosenthal F.S. The size distribution of droplets in the exhaled breath of healthy human subjects. J Aerosol Med 1997, 10:105-116.
3. Horváth I., Hunt J., Barnes P.J., et al. Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J 2005, 26:523-548.
4. Moeller A., Dompeling E. Exhaled breath condensates. Eur Respir Mon 2010, 155-182. U. Frey, P.J.F.M. Merkus (Eds.).
5. Montuschi P. New perspectives in monitoring lung inflammation: analysis of exhaled breath condensate 2005, CRC Press LLC, Boca Raton.
6. Jones C.W. Applications of hydrogen peroxide and derivatives 1999, The Royal Society of Chemistry, Cambridge.
7. Kawamura P.I., Mackay D. The evaporation of volatile liquids. J Hazard. Mater. 1987, 15:343-364.
8. Halliwell B., Clement M.V., Long L.H. Hydrogen peroxide in the human body. FEBS Lett 2000, 486:10-13.
9. Reth M. Hydrogen peroxide as second messenger in lymphocyte activation. Nat Immunol 2002, 3:1129-1134.
10. Brooks W.M., Lash H., Kettle A.J., Epton M.J. Optimising hydrogen peroxide measurement in exhaled breath condensate. Redox Rep 2006, 11:78-84.
11. Romero P.V., Rodríguez B., Martínez S., Cañizares R., Sepúlveda D., Manresa F. Analysis of oxidative stress in exhaled breath condensate from patients with severe pulmonary infections. Arch Bronconeumol 2006, 42:113-119.
12. Montuschi P. Analysis of exhaled breath condensate in respiratory medicine: methodological aspects and potential clinical applications. Ther Adv Respir Dis 2007, 1:5-23.
13. Rahman I., Biswas S.K. Non-invasive biomarkers of oxidative stress: reproducibility and methodological issues. Redox Rep 2004, 9:125-143.
14. Effros R.M., Hoagland K.W., Bosbous M., et al. Dilution of respiratory solutes in exhaled condensates. Am J Respir Crit Care Med 2002, 165:663-669.
15. Effros R.M. Metabolomics in exhaled breath condensates. Am J Respir Crit Care Med 2008, 177:236.
16. De Benedetto F., Aceto A., Dragani B., et al. Validation of a new technique to assess exhaled hydrogen peroxide: results from normals and COPD patients. Monaldi Arch Chest Dis 2000, 55:185-188.
17. van Beurden W.J., Harff G.A., Dekhuijzen P.N., van den Bosch M.J., Creemers J.P., Smeenk F.W. An efficient and reproducible method for measuring hydrogen peroxide in exhaled breath condensate. Respir Med 2002, 96:197-203.
18. Schleiss M.B., Holz O., Behnke M., Richter K., Magnussen H., Jörres R.A. The concentration of hydrogen peroxide in exhaled air depends on expiratory flow rate. Eur Respir J 2000, 16:1115-1118.
19. Sznajder J.I., Fraiman A., Hall J.B., et al. Increased hydrogen peroxide in the expired breath of patients with acute hypoxemic respiratory failure. Chest 1989, 96:606-612.
20. 2 in exhaled breath condensate during pregnancy-feasible effect of 17beta-estradiol. Respir Physiol Neurobiol 2008, 162:152-159.
21. 2 and pH in exhaled breath condensate samples: methodical and physiological aspects. Biomarkers 2008, 13:319-341.
22. Goldoni M., Caglieri A., Andreoli R., et al. Influence of condensation temperature on selected exhaled breath parameters. BMC Pulm Med 2005, 5:10.
23. Csoma Z., Huszár E., Vizi E., et al. Adenosine level in exhaled breath increases during exercise-induced bronchoconstriction. Eur Respir J 2005, 25:873-878.
24. Regamey N., Moeller A. Paediatric exercise testing. Eur Respir Mon 2010, 291-309. U. Frey, P.J.F.M. Merkus (Eds.).
25. Caglieri A., Goldoni M., Acampa O., et al. The effect of inhaled chromium on different exhaled breath condensate biomarkers among chrome-plating workers. Environ Health Perspect 2006, 114:2-6.
26. Rosias P.P.R., Robroeks C.M., van de Kant K.D., et al. Feasibility of a new method to collect exhaled breath condensate in pre-school children. Pediatr Allergy Immunol 2010, 21:e235-e244.
27. Dwyer T.M. Sampling airway surface liquid: non-volatiles in the exhaled breath condensate. Lung 2004, 182:241-250.
28. Zacharasiewicz A., Wilson N., Lex C., et al. Repeatability of sodium and chloride in exhaled breath condensates. Pediatr Pulmonol 2004, 37:273-275.
29. Baker E.H., Clark N., Brennan A.L., et al. Hyperglycemia and cystic fibrosis alter respiratory fluid glucose concentrations estimated by breath condensate analysis. J Appl Physiol 2007, 102:1969-1975.
30. Effros R.M., Biller J., Foss B., et al. A simple method for estimating respiratory solute dilution in exhaled breath condensates. Am J Respir Crit Care Med 2003, 168:1500-1505.
31. Lambert A.J., Buckingham J.A., Boysen H.M., Brand M.D. Low complex I content explains the low hydrogen peroxide production rate of heart mitochondria from the long-lived pigeon, Columbia livia. Aging Cell 2010, 9:78-91.
32. Frey R.S., Ushio-Fukai M., Malik A.B. NADPH oxidase-dependent signaling in endothelial cells: role in physiology and pathophysiology. Antioxid Redox Signal 2009, 11:791-810.
33. BelAiba R.S., Djordjevic T., Petry A., et al. NOX5 variants are functionally active in endothelial cells. Free Radic Biol Med 2007, 42:446-459.
34. Stefanska J., Sokolowska M., Sarniak A., et al. Apocynin decreases hydrogen peroxide and nirtate concentrations in exhaled breath in healthy subjects. Pulm Pharmacol Ther 2010, 23:48-54.
35. Kelley E.E., Khoo N.K., Hundley N.J., Malik U.Z., Freeman B.A., Tarpey M.M. Hydrogen peroxide is the major oxidant product of xanthine oxidase. Free Radic Biol Med 2010, 48:493-498.
36. Horvath I., Donnelly L.E., Kiss A., et al. Combined use of exhaled hydrogen peroxide and nitric oxide in monitoring asthma. Am J Respir Crit Care Med 1998, 158:1042-1046.
37. Svensson S., Olin A.C., Lärstad M., Ljungkvist G., Torén K. Determination of hydrogen peroxide in exhaled breath condensate by flow injection analysis with fluorescence detection. J Chromatogr B Analyt Technol Biomed Life Sci 2004, 809:199-203.
38. Cheson B.D., Christensen R.L., Sperling R., Kohler B.E., Babior B.M. The origin of the chemiluminescence of phagocytosing granulocytes. J Clin Invest 1976, 58:789-796.
39. 2 and thiobarbituric acid reactive substances (TBARs) by healthy subjects. Free Radic Biol Med 2001, 30:178-186.
40. Zappacosta B., Persichilli S., Mormile F., et al. A fast chemiluminescent method for H(2)O(2) measurement in exhaled breath condensate. Clin Chim Acta 2001, 310:187-191.
41. 2 in exhaled breath condensate. Anal Sci 2008, 24:201-205.
42. Gerritsen W.B., Zanen P., Bauwens A.A., van den Bosch J.M., Haas F.J. Validation of a new method to measure hydrogen peroxide in exhaled breath condensate. Respir Med 2005, 99:1132-1137.
43. Onoda M., Uchiyama T., Mawatari K., Kaneko K., Nakagomi K. Simple and rapid determination of hydrogen peroxide using phosphine-based fluorescent reagents with sodium tungstate dihydrate. Anal Sci 2006, 22:815-817.
44. Nozaki O., Kawamoto H. Determination of hydrogen peroxide by micro-flow injection-chemiluminescence using a coupled flow cell reactor chemiluminometer. Luminescence 2000, 15:137-142.
45. 2 based on nanopyramidal gold surface with enhanced electron transfer of myoglobin. Biosens Bioelectron 2009, 24:2470-2474.
46. 2 with high selectivity. Biosens Bioelectron 2009, 24:2465-2469.
47. van Beurden W.J., Dekhuijzen P.N., Harff G.A., Smeenk F.W. Variability of exhaled hydrogen peroxide in stable COPD patients and matched healthy controls. Respiration 2002, 69:211-216.
48. Loukides S., Bouros D., Papatheodorou G., Panagou P., Siafakas N.M. The relationships among hydrogen peroxide in expired breath condensate, airway inflammation, and asthma severity. Chest 2002, 121:338-346.
49. Szkudlarek U., Luczynska M., Kasielski M., Kalucka S., Nowak D. Exhaled hydrogen peroxide correlates with the release of reactive oxygen species by blood phagocytes in healthy subjects. Respir Med 2003, 97:718-725.
50. Rosias P.P., Den Hartog G.J., Robroeks C.M., et al. Detection of free radicals in EBC of children with CF and healthy subjects is feasible using EPR spectroscopy. Free Radic Res 2006, 40:901-909.
51. 2) levels in exhaled breath condensate in 9-year-old healthy children. Pediatr Pulmonol 2005, 39:41-45.
52. Gerritsen W.B., Asin J., Zanen P., van den Bosch J.M., Haas F.J. Markers of inflammation and oxidative stress in exacerbated chronic obstructive pulmonary disease patients. Respir Med 2005, 99:84-90.
53. Jensen D., Wolfe L.A., Slatkovska L., Webb K.A., Davies G.A., O'Donnell D.E. Effects of human pregnancy on the ventilatory chemoreflex response to carbon dioxide. Am J Physiol Regul Integr Comp Physiol 2005, 288:R1369-R1375.
54. Reinhold P., Jaeger J., Schroeder C. Evaluation of methodological and biological influences on the collection and composition of exhaled breath condensate. Biomarkers 2006, 11:118-142.
55. Taraldsřy T., Bolann B.J., Thorsen E. Reduced nitric oxide concentration in exhaled gas after exposure to hyperbaric hyperoxia. Undersea Hyperb Med 2007, 34:321-327.
56. Weissmann N., Schermuly R.T., Ghofrani H.A., et al. Hypoxic pulmonary vasoconstriction-triggered by an increase in reactive oxygen species?. Novartis Found Symp 2006, 272:196-208.
57. Latzin P., Griese M. Exhaled hydrogen peroxide, nitrite and nitric oxide in healthy children: decrease of hydrogen peroxide by atmospheric nitric oxide. Eur J Med Res 2002, 7:353-358.
58. Möller W., Heimbeck I., Weber N., et al. Fractionated exhaled breath condensate collection shows high hydrogen peroxide release in the airways. J Aerosol Med Pulm Drug Deliv 2010, 23:129-135.
59. Corradi M., Pignatti P., Brunetti G., et al. Comparison between exhaled and bronchoalveolar lavage levels of hydrogen peroxide in patients with diffuse interstitial lung diseases. Acta Biomed 2008, 79(Suppl 1):73-78.
60. Mercken E.M., Gosker H.R., Rutten E.P., et al. Systemic and pulmonary oxidative stress after single-leg exercise in COPD. Chest 2009, 136:1291-1300.
61. Jöbsis Q., Raatgeep H.C., Schellekens S.L., Hop W.C., Hermans P.W., de Jongste J.C. Hydrogen peroxide in exhaled air of healthy children: reference values. Eur Respir J 1998, 12:483-485.
62. Hitka P., Cernỳ M., Vízek M., Wilhelm J., Zoban P. Assessment of exhaled gases in ventilated preterm infants. Physiol Res 2004, 53:561-564.
63. Dohlman A.W., Black H.R., Royall J.A. Expired breath hydrogen peroxide is a marker of acute airway inflammation in pediatric patients with asthma. Am Rev Respir Dis 1993, 148:955-960.
64. Jobsis Q., Raatgeep H.C., Hermans P.W., de Jongste J.C. Hydrogen peroxide in exhaled air is increased in stable asthmatic children. Eur Respir J 1997, 10:519-521.
65. Antczak A., Nowak D., Shariati B., Krol M., Piasecka G., Kurmanowska Z. Increased hydrogen peroxide and thiobarbituric acid-reactive products in expired breath condensate of asthmatic patients. Eur Respir J 1997, 10:1235-1241.
66. Ganas K., Loukides S., Papatheodorou G., Panagou P., Kalogeropoulos N. Total nitrite/nitrate in expired breath condensate of patients with asthma. Respir Med 2001, 95:649-654.
67. Emelyanov A., Fedoseev G., Abulimity A., et al. Elevated concentrations of exhaled hydrogen peroxide in asthmatic patients. Chest 2001, 120:1136-1139.
68. Robroeks C.M., van de Kant K.D., Jobsis Q., et al. Exhaled nitric oxide and biomarkers in exhaled breath condensate indicate the presence, severity and control of childhood asthma. Clin Exp Allergy 2007, 37:1303-1311.
69. Al Obaidi A.H. Expired breath condensate hydrogen peroxide concentration and pH for screening cough variant asthma among chronic cough. Ann Thorac Med 2007, 2:18-22.
70. Dekhuijzen P.N., Aben K.K., Dekker I., et al. Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996, 154:813-816.
71. Nowak D., Kasielski M., Antczak A., Pietras T., Bialasiewicz P. Increased content of thiobarbituric acid-reactive substances and hydrogen peroxide in the expired breath condensate of patients with stable chronic obstructive pulmonary disease: no significant effect of cigarette smoking. Respir Med 1999, 93:389-396.
72. Fireman E., Shtark M., Priel I.E., et al. Hydrogen peroxide in exhaled breath condensate (EBC) vs eosinophil count in induced sputum (IS) in parenchymal vs airways lung diseases. Inflammation 2007, 30:44-51.
73. Kostikas K., Papatheodorou G., Psathakis K., Panagou P., Loukides S. Oxidative stress in expired breath condensate of patients with COPD. Chest 2003, 124:1373-1380.
74. Psathakis K., Mermigkis D., Papatheodorou G., et al. Exhaled markers of oxidative stress in idiopathic pulmonary fibrosis. Eur J Clin Invest 2006, 36:362-367.
75. Luczynska M., Szkudlarek U., Dziankowska-Bartkowiak B., et al. Elevated exhalation of hydrogen peroxide in patients with systemic sclerosis. Eur J Clin Invest 2003, 33:274-279.
76. Chow S., Campbell C., Sandrini A., Thomas P.S., Johnson A.R., Yates D.H. Exhaled breath condensate biomarkers in asbestos-related lung disorders. Respir Med 2009, 103:1091-1097.
77. Baldwin S.R., Simon R.H., Grum C.M., Ketai L.H., Boxer L.A., Devall L.J. Oxidant activity in expired breath of patients with adult respiratory distress syndrome. Lancet 1986, 1:11-14.
78. Kietzmann D., Kahl R., Muller M., Burchardi H., Kettler D. Hydrogen peroxide in expired breath condensate of patients with acute respiratory failure and with ARDS. Intensive Care Med 1993, 19:78-81.
79. Majewska E., Kasielski M., Luczynski R., Bartosz G., Bialasiewicz P., Nowak D. Elevated exhalation of hydrogen peroxide and thiobarbituric acid reactive substances in patients with community acquired pneumonia. Respir Med 2004, 98:669-676.
80. Stolarek R.A., Kasielski M., Rysz J., Bialasiewicz P., Nowak D. Differential effect of cigarette smoking on hydrogen peroxide and thiobarbituric acid reactive substances exhaled in patients with community acquired pneumonia. Monaldi Arch Chest Dis 2006, 65:19-25.
81. Kwiatkowska S., Szkudlarek U., Luczynska M., Nowak D., Zieba M. Elevated exhalation of hydrogen peroxide and circulating IL-18 in patients with pulmonary tuberculosis. Respir Med 2007, 101:574-580.
82. Loukides S., Horvath I., Wodehouse T., Cole P.J., Barnes P.J. Elevated levels of expired breath hydrogen peroxide in bronchiectasis. Am J Respir Crit Care Med 1998, 158:991-994.
83. Ho L.P., Faccenda J., Innes J.A., Greening A.P. Expired hydrogen peroxide in breath condensate of cystic fibrosis patients. Eur Respir J 1999, 13:103-106.
84. Robroeks C.M., Rosias P.P., van Vliet D., et al. Biomarkers in exhaled breath condensate indicate presence and severity of cystic fibrosis in children. Pediatr Allergy Immunol 2008, 19:652-659.
85. Jobsis Q., Raatgeep H.C., Schellekens S.L., Kroesbergen A., Hop W.C., de Jongste J.C. Hydrogen peroxide and nitric oxide in exhaled air of children with cystic fibrosis during antibiotic treatment. Eur Respir J 2000, 16:95-100.
86. 2 level in exhaled breath condensate in primary breast cancer patients. J Cancer Res Clin Oncol 2010, 136:923-930.
87. Petrosyan M., Perraki E., Simoes D., et al. Exhaled breath markers in patients with obstructive sleep apnoea. Sleep Breath 2008, 12:207-215.
88. Rysz J., Kasielski M., Apanasiewicz J., et al. Increased hydrogen peroxide in the exhaled breath of uraemic patients unaffected by haemodialysis. Nephrol Dial Transplant 2004, 19:158-163.
89. Jobsis R.Q., Schellekens S.L., Fakkel-Kroesbergen A., Raatgeep R.H., de Jongste J.C. Hydrogen peroxide in breath condensate during a common cold. Mediators Inflamm 2001, 10:351-354.
90. Heard S.O., Longtine K., Toth I., Puyana J.C., Potenza B., Smyrnios N. The influence of liposome-encapsulated prostaglandin E1 on hydrogen peroxide concentrations in the exhaled breath of patients with the acute respiratory distress syndrome. Anesth Analg 1999, 89:353-357.
91. Antczak A., Kurmanowska Z., Kasielski M., Nowak D. Inhaled glucocorticosteroids decrease hydrogen peroxide level in expired air condensate in asthmatic patients. Respir Med 2000, 94:416-421.
92. 2 and impaired lung function in patients undergoing bioincompatible hemodialysis. Int J Artif Organs 2007, 30:879-888.
93. Kasielski M., Nowak D. Long-term administration of N-acetylcysteine decreases hydrogen peroxide exhalation in subjects with chronic obstructive pulmonary disease. Respir Med 2001, 95:448-456.
94. De Benedetto F., Aceto A., Dragani B., et al. Long-term oral n-acetylcysteine reduces exhaled hydrogen peroxide in stable COPD. Pulm Pharmacol Ther 2005, 18:41-47.
95. van Beurden W.J., Smeenk F.W., Harff G.A., Dekhuijzen P.N. Markers of inflammation and oxidative stress during lower respiratory tract infections in COPD patients. Monaldi Arch Chest Dis 2003, 59:273-280.
96. van Beurden W.J., Harff G.A., Dekhuijzen P.N., van der Poel-Smet S.M., Smeenk F.W. Effects of inhaled corticosteroids with different lung deposition on exhaled hydrogen peroxide in stable COPD patients. Respiration 2003, 70:242-248.
97. Ferreira I.M., Hazari M.S., Gutierrez C., Zamel N., Chapman K.R. Exhaled nitric oxide and hydrogen peroxide in patients with chronic obstructive pulmonary disease: effects of inhaled beclomethasone. Am J Respir Crit Care Med 2001, 164:1012-1015.
98. Sandrini A., Ferreira I.M., Gutierrez C., Jardim J.R., Zamel N., Chapman K.R. Effect of montelukast on exhaled nitric oxide and nonvolatile markers of inflammation in mild asthma. Chest 2003, 124:1334-1340.
99. Emelyanov A., Fedoseev G., Krasnoschekova O., Abulimity A., Trendeleva T., Barnes P.J. Treatment of asthma with lipid extract of New Zealand green-lipped mussel: a randomised clinical trial. Eur Respir J 2002, 20:596-600.
100. Robroeks C.M., van de Kant K.D., van Vliet D., et al. Comparison of the anti-inflammatory effects of extra-fine hydrofluoroalkane-bseclomethasone vs. fluticasone dry powder inhaler on exhaled inflammatory markers in childhood asthma. Ann Allergy Asthma Immunol 2008, 100:601-607.
101. Gillissen A., Nowak D. Characterization of N-acetylcysteine and ambroxol in anti-oxidant therapy. Respir Med 1998, 92:609-623.
102. Rysz J., Stolarek R.A., Luczynski R., et al. Increased hydrogen peroxide concentration in the exhaled breath condensate of stable COPD patients after nebulized N-acetylcysteine. Pulm Pharmacol Ther 2007, 20:281-289.
103. Szkudlarek U., Zdziechowski A., Witkowski K., et al. Effect of inhaled N-acetylcysteine on hydrogen peroxide exhalation in healthy subjects. Pulm Pharmacol Ther 2004, 17:155-162.
104. Griese M., Noss J., von Bredow C. Protein pattern of exhaled breath condensate and saliva. Proteomics 2002, 2:690-696.